Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

M3 1P1Y Fund

Profile, fund size and leaders

Parent M3HQ Tokyo, JapanFounded 2019

M3 1P1Y Fund is the corporate venture arm of M3, a healthcare company. It was founded in 2019 and is based in Tokyo, Japan. Sectors it names: artificial intelligence, medical devices, healthcare and digital health, biotech and life sciences.

Commitment by parentS3
JPY 15bn
Companies backedS3
35

Every figure links to its source

Snapshot

Scale and capital allocated
Data behind this graphic
Data behind this graphic
MeasureValueUnitKindSource
Headline sizeJPY 15bnCommitment by parentStated by the firm or its parentS3
Companies backed35companiesStated by the firmS3

Sources: S3 M3: 1P1Y Fund investment line expanded to JPY 15B (press release).

Graphic 1 of 1

Scale and capital allocated

Firms and databases count companies, rounds and investments differently.

Sources: S3 M3: 1P1Y Fund investment line expanded to JPY 15B (press release).

Download:Report a correction

Where it invests and who leads it

Geography

Headquarters
Tokyo, Japan

Investment regionsS1

LeadersS1

M3 1P1Y Fund on LinkedIn

Key facts

FactValueStatusSource
Parent companyM3Single sourceS1
Parent industryHealthcare and life sciencesSingle sourceS1
Founded2019Single sourceS1
HeadquartersTokyo, JapanSingle sourceS1
StatusActiveSingle sourceS1
Capital sourceParent company onlySingle sourceS1
Headline sizeJPY 15bn (Commitment by parent)Single sourceS3
Companies backed35Single sourceS3

For founders

ItemWhat the firm saysSource
Check sizeJPY 100M to JPY 2bnS1

Fund vehicles

VehicleSizeYearSource
1P1Y FundJPY 15bn2019S3

Portfolio

Portfolio companies named in public sources: Kringle Pharma, Africa Health Holdings.S2

The firm also states 35 companies backed. The page list and the stated total measure different things.S3

Shared portfolio with other corporate VCs

1 companies on the M3 1P1Y Fund portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

FirmSharedCompanies in common
CEJ Capital1Kringle Pharma
The GOGIN Capital1Kringle Pharma

Companies backed by the most corporate VCs

Official pages

Read the firm's own pages for current information.

Sources

  1. S1M3: Launch of internal CVC 1P1Y Fund (press release)Firm
  2. S2M3: Full scale roll out of 1P1Y Fund (press release)Firm
  3. S3M3: 1P1Y Fund investment line expanded to JPY 15B (press release)Firm
  4. S4M3: Capital alliance with Africa Health Holdings (press release)Firm

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by M3 1P1Y Fund or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.